Table 2.
a. The serially diluted B19V standards of 1 × 101–106 copies per ul to measure the intra and inter repeatability | |||
---|---|---|---|
Plasmid copies(cp/μl) | B19. Ct (‾x ± s) | B19. CV (%) | |
Inter Repeatability | 1 × 106 | 15.91 ± 0.07 | 0.46 |
1 × 105 | 19.60 ± 0.08 | 0.41 | |
1 × 104 | 23.71 ± 0.05 | 0.21 | |
1 × 103 | 28.12 ± 0.25 | 0.91 | |
1 × 102 | 31.37 ± 0.20 | 0.64 | |
1 × 101 | 35.45 ± 0.63 | 1.80 | |
Intra Repeatability | 1 × 106 | 15.46 ± 0.66 | 4.80 |
1 × 105 | 19.86 ± 0.53 | 3.38 | |
1 × 104 | 23.86 ± 0.23 | 1.04 | |
1 × 103 | 27.99 ± 0.25 | 0.66 | |
1 × 102 | 31.42 ± 0.17 | 0.41 | |
1 × 101 | 35.21 ± 0.86 | 2.85 | |
b. The serially diluted CMV standards of 1 × 101–106 copies per ul to measure the intra and inter repeatability | |||
Plasmid copies(cp/μl) | CMV. Ct (‾x ± s) | CMV. CV (%) | |
Inter Repeatability | 1 × 106 | 15.52 ± 0.16 | 1.03 |
1 × 105 | 20.27 ± 0.5 | 2.50 | |
1 × 104 | 24.02 ± 0.69 | 2.87 | |
1 × 103 | 27.83 ± 0.15 | 0.52 | |
1 × 102 | 31.65 ± 0.61 | 1.94 | |
1 × 101 | 35.24 ± 0.23 | 0.64 | |
Intra Repeatability | 1 × 106 | 15.80 ± 0.43 | 2.93 |
1 × 105 | 20.72 ± 0.71 | 3.10 | |
1 × 104 | 24.43 ± 0.75 | 2.47 | |
1 × 103 | 28.26 ± 0.60 | 2.18 | |
1 × 102 | 32.36 ± 1.08 | 3.21 | |
1 × 101 | 35.88 ± 0.79 | 2.23 | |
c. The serially diluted HSV standards of 1 × 101–106 copies per ul to measure the intra and inter repeatability | |||
Plasmid copies(cp/μl) | HSV. Ct (‾x ± s) | HSV. CV (%) | |
Inter Repeatability | 1 × 106 | 16.03 ± 0.16 | 1.01 |
1 × 105 | 19.67 ± 0.11 | 0.56 | |
1 × 104 | 23.25 ± 0.03 | 0.11 | |
1 × 103 | 26.73 ± 0.18 | 0.66 | |
1 × 102 | 30.69 ± 0.52 | 1.70 | |
1 × 101 | 34.52 ± 1.06 | 3.07 | |
Intra Repeatability | 1 × 106 | 16.73 ± 0.68 | 4.32 |
1 × 105 | 20.31 ± 0.63 | 3.20 | |
1 × 104 | 24.02 ± 0.74 | 3.26 | |
1 × 103 | 27.51 ± 0.75 | 2.90 | |
1 × 102 | 31.48 ± 0.85 | 2.54 | |
1 × 101 | 35.84 ± 1.22 | 3.17 |
Ct Cycle threshold, CV Coefficient of Variation